Decreased cortical inhibition and yet cerebellar pathology in 'familial cortical myoclonic tremor with epilepsy'

Movement Disorders

Volumn 22, Issue 16, 2007, Pages 2378-2385

  Van Rootselaar, Anne Fleur ^a,c   Van Der Salm, Sandra M A ^a   Bour, Lo J ^a   Edwards, Mark J ^b   Brown, Peter ^b   Aronica, Eleonora ^c   Rozemuller Kwakkel, Johanna M ^c,d   Koehler, Peter J ^e   Koelman, Johannes H T M ^a   Rothwell, John C ^b   Tijssen, Marina A J ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^e Academic Medical Center ^*  (Netherlands)

Author keywords

Cerebellar Purkinje cell; Cortical myoclonus; Downbeat nystagmus; Epilepsy; Intracortical inhibition; Tremor

Indexed keywords

CARBAMAZEPINE; CLOBAZAM; CLONAZEPAM; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID;

ADULT; AGED; ARTICLE; CHANNELOPATHY; CLINICAL ARTICLE; CONTROLLED STUDY; EYE MOVEMENT DISORDER; FACILITATION; FEMALE; GABAERGIC TRANSMISSION; HUMAN; HYPERVENTILATION; MALE; MYOCLONUS EPILEPSY; NERVE CELL DEGENERATION; NEUROPATHOLOGY; NYSTAGMUS; OCULOGRAPHY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PURKINJE CELL; SACCADIC EYE MOVEMENT; SENSORIMOTOR CORTEX; SPINOCEREBELLAR DEGENERATION; TRANSCRANIAL MAGNETIC STIMULATION;

ADULT; AGED; AGED, 80 AND OVER; ANTICONVULSANTS; CEREBELLAR DISEASES; CEREBRAL CORTEX; ELECTROPHYSIOLOGY; EPILEPSIES, MYOCLONIC; EVOKED POTENTIALS, MOTOR; EYE MOVEMENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; NYSTAGMUS, PATHOLOGIC; PEDIGREE; PURSUIT, SMOOTH; SACCADES; TRANSCRANIAL MAGNETIC STIMULATION; TREMOR;

EID: 38549166211     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.21738     Document Type: Article

References (37)

1. Hallett M, Chadwick D, Marsden CD. Cortical reflex myoclonus. Neurology 1979;29:1107-1125.
2. Hunt JR. Dyssynergica cerebellaris myoclonica - primary atrophy of the dentate system. Brain 1921;44:490-538.
3. Tijssen MA, Thom M, Ellison DW, et al. Cortical myoclonus and cerebellar pathology. Neurology 2000;54:1350-1356.
4. Ikeda A, Kakigi R, Funai N, Neshige R, Kuroda Y, Shibasaki H. Cortical tremor: a variant of cortical reflex myoclonus. Neurology 1990;40:1561-1565.
5. Striano P, Zara F, Striano S. Autosomal dominant cortical tremor, myoclonus and epilepsy: many syndromes, one phenotype. Acta Neurol Scand 2005;111:211-217.
6. van Rootselaar AF, van Schaik IN, van den Maagdenberg AM, Koelman JH, Callenbach PM, Tijssen MA. Familial cortical myo-clonic tremor with epilepsy: a single syndromic classification for a group of pedigrees bearing common features. Mov Disord 2005;20:665-673.
7. van Rootselaar AF, Maurits NM, Koelman JH, et al. Coherence analysis differentiates between cortical myoclonic tremor and essential tremor. Mov Disord 2006;21:215-222.
8. Guerrini R, Bonanni P, Patrignani A, et al. Autosomal dominant cortical myoclonus and epilepsy (ADCME) with complex partial and generalized seizures: a newly recognized epilepsy syndrome with linkage to chromosome 2p11.1-q12.2. Brain 2001;124(Part 12):2459-2475.
9. van Rootselaar AF, Aronica E, Jansen Steur EN, Rozemuller-Kwakkel JM, de Vos RA, Tijssen MA. Familial cortical tremor with epilepsy and cerebellar pathological findings. Mov Disord 2004;19:213-217.
10. Leigh RJ, Zee DS. The diagnostic value of abnormal eye movements: a pathophysiological approach. Johns Hopkins Med J 1982;151:122-135.
11. Zee DS, Leigh RJ, Mathieu-Millaire F. Cerebellar control of ocular gaze stability. Ann Neurol 1980;7:37-40.
12. van Rootselaar F, Callenbach PM, Hottenga JJ, et al. A Dutch family with 'familial cortical tremor with epilepsy'. Clinical characteristics and exclusion of linkage to chromosome 8q23.3-q24.1. J Neurol 2002;249:829-834.
13. Bour LJ, Aramideh M, de Visser BW. Neurophysiological aspects of eye and eyelid movements during blinking in humans. J Neurophysiol 2000;83:166-176.
14. Deuschl G, Eisen AA. Recommendations for the Practice of clinical neurophysiology: guidelines of the international federation of clinical neurophysiology, 2nd revised and Enlarged ed. Amsterdam: Elsevier; 1999.
15. Kujirai T, Caramia MD, Rothwell JC, et al. Corticocortical inhibition in human motor cortex. J Physiol 1993;471:501-519.
16. Crooks R, Mitchell T, Thom M. Patterns of cerebellar atrophy in patients with chronic epilepsy: a quantitative neuropathological study. Epilepsy Res 2000;41:63-73.
17. Yang Q, Hashizume Y, Yoshida M, et al. Morphological Purkinje cell changes in spinocerebellar ataxia type 6. Acta Neuropathol (Berl) 2000;100:371-376.
18. Hilton EJ, Hosking SL, Betts T. The effect of antiepileptic drugs on visual performance. Seizure 2004;13:113-128.
19. Berger JR, Kovacs AG. Downbeat nystagmus with phenytoin. J Clin Neuroophthalmol 1982;2:209-211.
20. Chrousos GA, Cowdry R, Schuelein M, Abdul-Rahim AS, Matsuo V, Currie JN. Two cases of downbeat nystagmus and oscillopsia associated with carbamazepine. Am J Ophthalmol 1987;103:221-224.
21. Hadjikoutis S, Morgan JE, Wild JM, Smith PE. Ocular complications of neurological therapy. Eur J Neurol 2005;12:499-507.
22. Kalla R, Deutschlander A, Hufner K, et al. Detection of floccular hypometabolism in downbeat nystagmus by fMRI. Neurology 2006;66:281-283.
23. Pierrot-Deseilligny C, Milea D. Vertical nystagmus: clinical facts and hypotheses. Brain 2005;128(Part 6): 1237-1246.
24. Walker MF, Zee DS. The effect of hyperventilation on downbeat nystagmus in cerebellar disorders. Neurology 1999;53:1576-1579.
25. Kalla R, Deutschlander A, Hufner K, et al. Detection of floccular hypometabolism in downbeat nystagmus by fMRI. Neurology 2006;66:281-283.
26. Cantello R. Applications of transcranial magnetic stimulation in movement disorders. J Clin Neurophysiol 2002;19:272-293.
27. Ziemann U. TMS and drugs Clin Neurophysiol 2004;115:1717-1729.
28. Ziemann U. Pharmacology of TMS. Suppl Clin Neurophysiol 2003;56:226-231.
29. Daskalakis ZJ, Paradiso GO, Christensen BK, Fitzgerald PB, Gunraj C, Chen R. Exploring the connectivity between the cerebellum and motor cortex in humans. J Physiol 2004;557(Part 2):689-700.
30. Liepert J, Wessel K, Schwenkreis P, et al. Reduced intracortical facilitation in patients with cerebellar degeneration. Acta Neurol Scand 1998;98:318-323.
31. Schwenkreis P, Tegenthoff M, Witscher K, et al. Motor cortex activation by transcranial magnetic stimulation in ataxia patients depends on the genetic defect. Brain 2002;125 (Part 2):301-309.
32. Gutierrez-Delicado E, Serratosa JM. Genetics of the epilepsies. Curr Opin Neurol 2004;17:147-153.
33. Kaneko S, Iwasa H, Okada M. Genetic identifiers of epilepsy. Epilepsia 2002;43(Suppl 9):16-20.
34. Mulley JC, Scheffer IE, Petrou S, Berkovic SF. Channelopathies as a genetic cause of epilepsy. Curr Opin Neurol 2003;16:171-176.
35. Zhuchenko O, Bailey J, Bonnen P, et al. Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel. Nat Genet 1997;15:62-69.
36. Kimiskidis VK, Papagiannopoulos S, Kazis DA, et al. Lorazepam-induced effects on silent period and corticomotor excitability. Exp Brain Res 2006;173:603-611.
37. Brouwer OF, Callenbach PMC, van Rootselaar F, et al. A Dutch family with 'familial cortical tremor with epilepsy': exclusion of linkage to chromosomes 8q and 2p. Epilepsia 128: 2002. (Abstract).